Pancreatic Cancer Research

ResearcherGeisinger Medical CenterActive in the last 2 years

Joseph Blansfield

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1652-3274; OpenAlex author ID A5084142757. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. Trend of Adjuvant Radiation in Resected Pancreatic Ductal Adenocarcinoma: Evaluation of RTOG 0848 with a Large National Database. First author DOI 10.1007/s12029-026-01492-0↗
  2. Lymph node yield as a measure of pancreatic cancer surgery quality. Last author DOI 10.1016/j.sipas.2022.100103↗
  3. Analyzing the Impact of Compliance with National Guidelines for Pancreatic Cancer Care Using the National Cancer Database. Last author DOI 10.1007/s11605-018-3742-9↗
  4. Neoadjuvant versus Adjuvant Chemotherapy for Resectable Pancreatic Adenocarcinoma: A National Cancer Database Analysis. Last author DOI 10.1177/000313481808400946↗
  5. Investigating the prognostic value of KOC (K homology domain containing protein overexpressed in cancer) overexpression after curative intent resection of panc… Co-author DOI 10.21037/jgo.2016.11.05↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Erin M. Dickey · 1 shared paper, 2026 · strength 0.39
  2. Neda Amini · 1 shared paper, 2026 · strength 0.39
  3. Kevin Zhao · 1 shared paper, 2022 · strength 0.19
  4. Kathryn Jaap · 1 shared paper, 2018 · strength 0.09
  5. Ammar Hashmi · 1 shared paper, 2018 · strength 0.09
  6. Alva Bowen Weir · 1 shared paper, 2016 · strength 0.07
  7. Benny Johnson · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.